Bokhari Wasiq Mahmood bought PSQL

Footnotes

Received pursuant to the consummation of the Issuer's business combination, in connection with the Agreement and Plan of Merger, dated as of February 28, 2026 (as amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement"), by and among Bleichroeder Acquisition Corp. II ("Bleichroeder"), Bleichroeder Acquisition France Merger Sub 2 ("Merger Sub"), and Pasqal Holding SAS ("Legacy Pasqal"), which provided for, among other things and subject to the terms and conditions contained in the Business Combination Agreement,; Footnote 1 continued-(i) the merger of Bleichroeder with and into Merger Sub, with Merger Sub continuing as the surviving company (the "Reincorporation Merger", and Merger Sub as the surviving company of the Reincorporation Merger, the "Bleichroeder Surviving Corporation") and (ii) the merger of Legacy Pasqal with and into the Bleichroeder Surviving Corporation, with the Bleichroeder Surviving Corporation continuing as the surviving company and changing its name to "Pasqal Holding SA" (the "Merger").; The exercise price is EUR 50.; Pursuant to the Merger, legacy BSPCEs of Legacy Pasqal were assumed by the Issuer, granting each holder the right to subscribe for ordinary shares of the Issuer, with the number of underlying shares adjusted, as applicable, to reflect the exchange ratio of 22.7361449900136 set forth in the Business Combination Agreement.; As of the date hereof, 260,611 of the BSPCEs have fully vested and are exercisable for 5,925,289 ordinary shares of the Issuer. The remaining BSPCEs will vest in equal monthly installments of (i) 4,100 BSPCEs from September 1, 2026 to July 1, 2028, (ii) 2,885 BSPCEs from September 1, 2026 to January 1, 2029, and (iii) 6,880 BSPCEs from September 1, 2026 to July 1, 2029.